V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20158734 | 20060829 | 1.43 | 57.3 | Adjuvant (A) | 2018-01-02 | 2018-01-14 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100447402 |
| 20158737 | 20060830 | 1.49 | 78.5 | Neo-adjuvant (N) | 2018-07-21 | 2018-07-26 | ECX | 02 | N | ECX | 101264438 |
| 20158739 | 20060831 | 1.75 | 86 | Palliative (P) | 2017-07-10 | 2017-07-10 | ECX | N | N | ECX | 100320176 |
| 20158740 | 20060832 | 1.61 | 67.5 | null | 2017-02-13 | 2017-02-27 | ECX | N | N | CAPECITABINE + GEMCITABINE | 100511636 |
| 20158741 | 20060833 | 1.7 | 61 | Palliative (P) | 2017-09-03 | 2017-09-09 | ECX | 02 | N | ECX | 101861949 |
| 20158742 | 20060834 | 1.6 | 86.6 | Palliative (P) | 2019-08-08 | 2019-08-25 | ECX | N | N | ECX | 100336582 |
| 20158744 | 20060835 | 1.75 | 56.8 | null | 2016-01-23 | 2016-02-11 | ECX | 02 | N | CAPECITABINE + GEMCITABINE | 100062304 |
| 20158747 | 20060836 | 1.49 | 57 | Neo-adjuvant (N) | 2020-01-27 | 2020-02-03 | ECX | N | N | ECX | 100172339 |
| 20158750 | 20060837 | 1.73 | 129.8 | null | null | 2019-11-14 | ECX | N | N | ECX | 100228542 |
| 20158752 | 20060838 | 1.7 | 95 | Neo-adjuvant (N) | 2019-01-22 | 2019-02-06 | ECX | N | N | ECX | 100553764 |
| 20158754 | 20060839 | 1.42 | 63.4 | Adjuvant (A) | 2016-02-22 | 2016-03-06 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100286741 |
| 20158755 | 20060840 | 1.86 | 111.5 | Palliative (P) | 2016-11-20 | 2016-12-10 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100149049 |
| 20158756 | 20060841 | 1.58 | 102 | Palliative (P) | 2016-10-29 | 2016-11-02 | ECX | null | N | CAPECITABINE + GEMCITABINE | 100416538 |
| 20158757 | 20060842 | 1.56 | 43.9 | null | 2020-01-26 | 2020-01-29 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 100209890 |
| 20158758 | 20060843 | 1.6 | 47.5 | Palliative (P) | 2017-10-09 | 2017-11-03 | ECX | N | N | ECX | 100832168 |
| 20158760 | 20060844 | 1.67 | 53.9 | Adjuvant (A) | 2017-06-03 | 2017-06-18 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100606122 |
| 20158761 | 20060845 | 1.72 | 62.3 | Adjuvant (A) | 2016-08-07 | 2016-08-26 | ECX | 2 | N | ECX | 100097667 |
| 20158762 | 20060846 | 1.83 | 50.7 | Curative (C) | null | 2016-12-21 | ECX | N | N | ECX | 101201768 |
| 20158764 | 20060847 | 1.69 | 77.2 | Palliative (P) | 2018-10-20 | 2018-10-30 | ECX | N | N | ECX | 100771791 |
| 20158765 | 20060848 | 1.78 | 78.4 | Neo-adjuvant (N) | 2019-09-20 | 2019-09-21 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 101360427 |
| 20158768 | 20060849 | 1.8 | 120 | Palliative (P) | 2020-01-01 | 2020-01-08 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101813962 |
| 20158770 | 20060850 | 1.67 | 82.6 | Neo-adjuvant (N) | 2017-03-01 | 2017-03-10 | ECX | 02 | N | ECX | 100535452 |
| 20158771 | 20060851 | 1.83 | 66.4 | Neo-adjuvant (N) | 2016-12-14 | 2017-01-02 | ECX | N | N | ECX | 101491342 |
| 20158772 | 20060852 | 1.58 | 96 | Palliative (P) | null | 2016-12-27 | ECX | 02 | N | CAPECITABINE + GEMCITABINE | 100929789 |
| 20158773 | 20060853 | 1.7 | 74.4 | Neo-adjuvant (N) | 2018-03-12 | 2018-03-19 | ECX | N | N | ECX | 100694996 |
| 20158774 | 20060854 | 1.68 | 66.9 | Neo-adjuvant (N) | 2018-08-25 | 2018-09-21 | ECX | 02 | N | ECX | 100020881 |
| 20158775 | 20060855 | 1.65 | 69.2 | Curative (C) | 2018-08-24 | 2018-08-24 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100904498 |
| 20158776 | 20060856 | 1.9 | 57.2 | Palliative (P) | 2019-11-02 | 2019-11-13 | ECX | N | N | ECX | 101773635 |
| 20158777 | 20060857 | 1.84 | 58 | Palliative (P) | 2017-09-05 | 2017-09-05 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100552309 |
| 20158780 | 20060858 | 1.54 | 55.2 | Palliative (P) | 2016-08-08 | 2016-08-20 | ECX | N | N | ECX | 101621832 |
| 20158781 | 20060859 | 1.7 | 60.8 | Neo-adjuvant (N) | 2019-11-07 | 2019-11-07 | ECX | 02 | N | ECX | 101146875 |
| 20158782 | 20060860 | 1.79 | 41 | Palliative (P) | 2016-08-01 | 2016-08-01 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100290930 |
| 20158783 | 20060861 | 1.58 | 68.6 | null | null | 2018-10-12 | ECX | null | N | ECX | 100386484 |
| 20158784 | 20060862 | null | 41.4 | Palliative (P) | 2021-08-13 | 2021-08-24 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 101010040 |
| 20158787 | 20060863 | 1.68 | 73.5 | Palliative (P) | 2017-01-15 | 2017-01-19 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101234999 |
| 20158788 | 20060864 | 1.63 | 74.3 | Neo-adjuvant (N) | 2017-06-23 | 2017-07-06 | ECX | 02 | N | ECX | 100617840 |
| 20158789 | 20060865 | 1.61 | 54.6 | Palliative (P) | 2019-11-01 | 2019-11-15 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101537849 |
| 20158790 | 20060866 | 1.64 | 65.35 | Palliative (P) | 2018-10-14 | 2018-10-19 | Gemcitabine + Capecitabine | N | N | CAPECITABINE + GEMCITABINE | 101719682 |
| 20158791 | 20060867 | 1.57 | 65.4 | Curative (C) | null | 2016-10-07 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 101473959 |
| 20158792 | 20060868 | 1.8 | 74 | Radical (R) | 2019-08-21 | 2019-09-08 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100400107 |
| 20158793 | 20060869 | 1.6 | 73.4 | Adjuvant (A) | 2019-03-06 | 2019-03-31 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100118617 |
| 20158796 | 20060870 | 1.6 | 64.3 | Palliative (P) | 2018-05-06 | 2018-05-20 | ECX | null | N | ECX | 100874296 |
| 20158797 | 20060871 | 1.7 | 76.7 | Palliative (P) | 2016-08-15 | 2016-09-05 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101174946 |
| 20158798 | 20060872 | 1.65 | 78.4 | Palliative (P) | 2017-04-08 | 2017-04-10 | Gemcitabine + Capecitabine | N | null | CAPECITABINE + GEMCITABINE | 100448105 |
| 20158799 | 20060873 | 1.68 | 59.4 | Neo-adjuvant (N) | null | 2018-04-08 | ECX | N | N | ECX | 101505939 |
| 20158801 | 20060874 | 1.56 | 62.4 | Neo-adjuvant (N) | 2016-06-04 | 2016-06-20 | CAPECITABINE + GEMCITABINE | N | N | CAPECITABINE + GEMCITABINE | 100408833 |
| 20158802 | 20060875 | 1.73 | 92.8 | Adjuvant (A) | 2019-03-07 | 2019-03-07 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101211685 |
| 20158804 | 20060876 | 1.55 | 59.2 | Palliative (P) | 2017-01-02 | 2017-01-02 | ECX | 02 | N | ECX | 101071472 |
| 20158810 | 20060877 | 1.7 | 93.85 | Neo-adjuvant (N) | 2016-05-17 | 2016-05-20 | ECX | 02 | N | ECX | 101863342 |
| 20158811 | 20060878 | 1.81 | 104 | Palliative (P) | 2016-09-29 | 2016-09-29 | Gemcitabine + Capecitabine | N | N | CAPECITABINE + GEMCITABINE | 100288546 |